CH Biotech R&D Co Ltd (6534)

Currency in TWD
93.00
+0.90(+0.98%)
Closed·
6534 Scorecard
Full Analysis
Impressive gross profit margins
High dividend Yield
6534 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
92.2093.80
52 wk Range
71.1099.50
Key Statistics
Bid/Ask
51.00 / 53.30
Prev. Close
100.5
Open
92.2
Day's Range
92.2-93.8
52 wk Range
71.1-99.5
Volume
30.49K
Average Volume (3m)
66.66K
1-Year Change
-8.36%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6534 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Cash flows can sufficiently cover interest payments

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

CH Biotech R&D Co Ltd Company Profile

CH Biotech R&D Co., Ltd., a biotech company, engages in the research and development of biotech drugs for agrochemical products in Taiwan, the United States, and internationally. The company offers plant growth regulators and fertilizers; and biotechnology services. CH Biotech R&D Co., Ltd. was incorporated in 2013 and is based in Nantou City, Taiwan.

Industry
Chemicals
0
Market
Taiwan

Compare 6534 to Peers and Sector

Metrics to compare
6534
Peers
Sector
Relationship
P/E Ratio
26.0x41.8x2.2x
PEG Ratio
−1.470.070.00
Price/Book
3.5x0.9x1.6x
Price / LTM Sales
5.6x0.5x1.3x
Upside (Analyst Target)
-29.9%20.0%
Fair Value Upside
Unlock−1.1%2.4%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.54%
Dividend Yield
4.41%
Industry Median 2.89%
Annualised payout
4.10
Paid annually
5-Years Growth
+31.63%
Growth Streak

Earnings

Latest Release
Aug 05, 2025
EPS / Forecast
0.37 / --
Revenue / Forecast
420.48M / --
EPS Revisions
Last 90 days

6534 Income Statement

FAQ

What Stock Exchange Does CH Biotech R&D Trade On?

CH Biotech R&D is listed and trades on the Taiwan Stock Exchange stock exchange.

What Is the Stock Symbol for CH Biotech R&D?

The stock symbol for CH Biotech R&D is "6534."

What Is the CH Biotech R&D Market Cap?

As of today, CH Biotech R&D market cap is 9.56B.

What Is CH Biotech R&D's Earnings Per Share (TTM)?

The CH Biotech R&D EPS (TTM) is 3.54.

When Is the Next CH Biotech R&D Earnings Date?

CH Biotech R&D will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is 6534 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has CH Biotech R&D Stock Split?

CH Biotech R&D has split 6 times.

How Many Employees Does CH Biotech R&D Have?

CH Biotech R&D has 0 employees.

What is the current trading status of CH Biotech R&D (6534)?

As of 09 Aug 2025, CH Biotech R&D (6534) is trading at a price of 93.00, with a previous close of 100.50. The stock has fluctuated within a day range of 92.20 to 93.80, while its 52-week range spans from 71.10 to 99.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.